Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
5,280.00
-10.00 (-0.19%)
At close: Nov 14, 2025
Sinsin Pharmaceutical Revenue
Sinsin Pharmaceutical had revenue of 29.60B KRW in the quarter ending June 30, 2025, with 0.47% growth. This brings the company's revenue in the last twelve months to 107.13B, up 1.79% year-over-year. In the year 2024, Sinsin Pharmaceutical had annual revenue of 106.39B with 3.71% growth.
Revenue (ttm)
107.13B
Revenue Growth
+1.79%
P/S Ratio
0.74
Revenue / Employee
300.92M
Employees
356
Market Cap
79.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106.39B | 3.80B | 3.71% |
| Dec 31, 2023 | 102.59B | 10.66B | 11.60% |
| Dec 31, 2022 | 91.93B | 17.92B | 24.21% |
| Dec 31, 2021 | 74.01B | 6.88B | 10.25% |
| Dec 31, 2020 | 67.13B | -725.72M | -1.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.59T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 111.04T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 19.25T |
| Doosan Enerbility | 16.30T |
| HD Hyundai Heavy Industries | 15.58T |